90 Day Notice for Pharmacy Utilization Management Requirements
Effective July 1, 2021, Blue Cross and Blue Shield of North Carolina (Blue Cross NC) will have changes to our pharmacy utilization management (UM) requirements.
Our UM requirements apply to all commercial members with pharmacy benefit coverage through Blue Cross NC. These changes do not affect State Health Plan, Federal Employee Program, Medicare Part D members, or any self-funded employer groups that carve out pharmacy benefits to another pharmacy benefits manager (PBM).
Below is a summary of the changes.
NEW REQUIREMENTS
Impacted Medications | Requirement |
---|---|
Actimmune | This medication will require Prior Authorization. |
Advair, AirDuo, Alvesco, Anoro Ellipta, Arcapta Neohaler, ArmonAir, Arnuity Ellipta, Asmanex, Atrovent HFA, Bevespi Aerosphere, Breo Ellipta, Breztri, Combivent Respimat, Duklair Pressair, Dulera, Flovent, Incruse Ellipta, Pulmicort, QVAR, Seebri Neohaler, Serevent Diskus, Spiriva, Stiolto, Striverdi, Symbicort, Trelegy, Tudorza, Utibron, Wixkela | These medication will require Quantity Limits. |
Arcalyst | This medication will require Prior Authorization and Quantity Limits. |
Flunisolide Nasal Spray | This medication will require Step Therapy on the Essential formulary. The preferred products will be over-the-counter intranasal steroid products. |
Invokana, Invokamet, Invokamet XR | These medications will require Step Therapy. The preferred products will be Farxiga, Jardiance, Trijardy and Xigduo XR. |
Levocetirizine solution, Desloratadine ODT, Prevacid ODT, Phoslyra solution | hese medications will require Prior Authorization. Prior Authorization will only apply for members > 11 years of age. |
Lidocaine-Prilocaine 2.5-2.5% | This medication will require Prior Authorization, Step Therapy and Quantity Limits. |
Prolate tablets | This medication will require Prior Authorization and Step Therapy. The preferred products will be oxycodone w/ acetaminophen 5-325mg, oxycodone w/ acetaminophen 7.5-325mg, or oxycodone w/ acetaminophen 10-325mg. |
Protonix tablets, Aciphex tablets | These medications will require Step Therapy. The preferred products will be over-the-counter proton pump inhibitors. |
Truvada 200-300mg, Descovy | These medications will require Quantity Limits. |
UPDATED REQUIREMENTS
Impacted Medications | Requirements | |
---|---|---|
Hetlioz tablets | This medication will require Step Therapy and Quantity Limits. | |
Nefazodone, Carisoprodol, Carisoprodol/ASA, Thioridazine | The requirements of Prior Authorization and Step Therapy already on Enhanced will be added to Essential and Net Results formularies. | |
ProAir, Proventil, Ventolin, Xopenex | The Quantity Limits of this medication will decrease from 6 inhalers per day to 2 inhalers per 30 days. | |
Xtandi 40mg capsules | The Quantity Limits of this medication will decrease from 4 capsules per day to 3 capsules per day. |
If you have any questions, please call the Provider Blue Line℠ at 800-214-4844.
Blue Cross and Blue Shield of North Carolina does not discriminate on the basis of race, color, national origin, sex, age or disability in its health programs and activities. Learn more about our non-discrimination policy and no-cost services available to you.
Information in other languages: Español 中文 Tiếng Việt 한국어 Français العَرَبِيَّة Hmoob ру́сский Tagalog ગુજરાતી ភាសាខ្មែរ Deutsch हिन्दी ລາວ 日本語
© 2024 Blue Cross and Blue Shield of North Carolina. ®, SM Marks of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield plans. All other marks and names are property of their respective owners. Blue Cross and Blue Shield of North Carolina is an independent licensee of the Blue Cross and Blue Shield Association.